AVAXZIPEN
aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.
AVAXZIPEN
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.avaxzipen.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 1235 577 120
Email Addresses:
[email protected]
Total Funding:
1.6 M USD
Technology used in webpage:
Google Maps Catalyst2 Services
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Funding Round - aVaxziPen
Official Site Inspections
http://www.avaxzipen.com
- Host name: server.ncserver.co.uk
- IP address: 62.100.204.187
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "aVaxziPen"
Avaxzipen | Needle Free Vaccines
Carolyn joined aVaxziPen in August 2023. Carolyn was originally a research scientist, gaining her PhD in Molecular Virology in 2007 from Oxford Brookes University, before qualifying as a …See details»
aVaxziPen Company Profile 2024: Valuation, Funding
AVaxziPen General Information Description. Operator of a clinical-stage pharmaceutical company intended to develop innovative drug-device …See details»
aVaxziPen - Crunchbase Company Profile & Funding
When was the last funding round for aVaxziPen? aVaxziPen closed its last funding round on Jun 6, 2023 from a Undisclosed round. Who are aVaxziPen 's competitors? Alternatives and …See details»
Needle-free vaccine delivery platform aims to end …
June 6, 2023; OSLO, Norway and OXFORD, UK: CEPI, the Coalition for Epidemic Preparedness Innovations, and aVaxziPen Ltd, a biotech company developing a novel needle-free vaccine delivery platform, have today …See details»
AVAXZIPEN LIMITED overview - Find and update company …
Charges for AVAXZIPEN LIMITED (10908112) More for AVAXZIPEN LIMITED (10908112) Registered office address 120a&B Olympic Avenue, Milton Park, Abingdon, Oxfordshire, …See details»
aVaxziPen Company Profile: Overview and Full News Analysis
AVaxziPen, located in Oxfordshire, is a company focused on developing a novel vaccine delivery platform known as aVaxziPen™. Their innovative technology aims to provide a robust immune …See details»
AVAXZIPEN LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AVAXZIPEN LIMITED of ABINGDON. Get the latest business insights from Dun & Bradstreet. AVAXZIPEN …See details»
aVaxziPen - Funding, Financials, Valuation & Investors - Crunchbase
Jun 6, 2023 aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
aVaxziPen Limited - LinkedIn
AVaxziPen Limited Biotechnology Research Abingdon, GB 1,315 followers Thermally Stable, Needle Free, Solid Dose VaccinesSee details»
aVaxziPen and CEPI team up for needle-free vaccine tech - Digital …
Jun 12, 2023 A partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and biotech company aVaxziPen, is hoping to improve access to vaccines by removing …See details»
AVAXZIPEN LIMITED - Companies House
AVAXZIPEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Needle-free vaccine delivery platform aims to end frozen storage …
June 6, 2023; OSLO, Norway and OXFORD, UK: CEPI, the Coalition for Epidemic Preparedness Innovations, and aVaxziPen Ltd, a biotech company developing a novel needle-free vaccine …See details»
AVAXZIPEN LIMITED people - Find and update company …
Charges for AVAXZIPEN LIMITED (10908112) More for AVAXZIPEN LIMITED (10908112) Officers; Persons with significant control; Filter officers Filter officers Current officers Officers: …See details»
aVaxziPen | Insights
Oct 15, 2015 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Small Business - The Coastland Times | The Coastland Times
Apr 3, 2023 Dr Keith Howard, aVaxziPen’s CSO, said, “With our needle-free technology we’re on a mission to transform vaccine delivery for the benefit of communities around the world. …See details»
aVaxziPen Announces Positive Data in Multiple Diseases on Novel …
Apr 4, 2023 In vivo data demonstrates immune equivalence to traditional needle and syringe injection when using a needle-free solid dose formulation . Oxford, UK, 3 April 2023 – …See details»
AVAXZIPEN LIMITED filing history - Companies House
AVAXZIPEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Research programme: measles and rubella vaccines - aVaxziPen
AVaxziPen (formerly Enesi Pharma) is developing solid-dose, thermo-stable live vaccines against measles and rubella, by using its proprietary needle-free solid ... If your organization has a …See details»
Research programme: infectious disease vaccines
AVaxziPen (formerly Enesi Pharma) and Geovax are collaborating to evaluate solid dose, needle-free vaccines against a range of infectious diseases (infections ... If your organization has a …See details»
aVaxziPen - Company Profile - Tracxn
AVaxziPen - Developer of formulation vaccine delivery device. aVaxziPen has 52 competitors.See details»